Compensation for thalidomide rejected by Spain’s Supreme Court

10/01/2015 // JusticeNewsFlash // (press release)

Madrid – Individuals who claim to have suffered birth defects after taking the pregnancy drug thalidomide are not due compensation by a German drug manufacturer, according to a recent ruling by Spain’s Supreme Court. The court upheld a ruling by a lower court that does not require Grunenthal to pay due to the expiration of the statute of limitations in the plaintiffs’ case, as reported by AFP.

In 2013, a lower court had ordered a payment of 20,000 euros ($22,300) for each percentage point of disability victims suffered that were recognized by Spain’s Health Ministry. The ruling was appealed by Grunenthal.

The recent high court ruling left open room for future civil claims for compensation.

Ignacio Marinez, an attorney for the victims, is quoted as stating of the case “We will continue the fight and will go before the Constitutional Court and the European Court of Human Rights.

Thalidomide was prescribed from the late 1950s for morning sickness. It was withdrawn from British and German markets in 1961. An estimated 10,000 to 20,000 babies in various countries were born with deformities as a result of the drug reports say.

Read more about Defective Drug Lawsuits on Justice News Flash follow our Defective Drug News

More stories related to Defective Drugs /?s=defective+drugs

Source: AFP News Story;_ylt=AwrC1CmqHw1WKXwA0m3QtDMD;_ylu=X3oDMTByNXM5bzY5BGNvbG8DYmYxBHBvcwMzBHZ0aWQDBHNlYwNzcg–

Media Information:

Phone: 866-598-1315